ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "microbiome"

  • Abstract Number: 1644 • ACR Convergence 2023

    The EISER Study: Identifying Microbial Factors Associated with Subclinical Gut Inflammation in Spondyloarthritis Patients

    Alba Boix-Amorós1, Rebecca Blank2, Adam Cantor1, Jesus Sanz3, Ana Gutiérrez-Casbas4, Jordi Gratacos Masmitja5, Iago Rodríguez -Lago6, Elisa Trujillo7, Ignacio Marin-Jimenez8, Zulema Plaza9, Marta Domínguez10, Jose Federico Diaz-Gonzalez11, Juan D Canete12, Jose Scher13 and Jose Clemente1, 1Icahn School of Medicine, New York, NY, 2New York University, New York, NY, 3Hospital Universitario Puerta de Hierro, Majadahonda, Spain, 4Hospital General Universitario Dr. Balmis, Alicante, Spain, 5University Hospital Parc Taulí, Sabadell, Spain, 6Gastroenterology department Hospital Galdakao, Galdakao, Spain, 7Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 8Public Health System, Madrid, Spain, 9Universidad Autónoma de Madrid, Madrid, Spain, 10Sociedad Española de Reumatología, Madrid, Spain, 11Hospital Universitario de Canarias, La Laguna, Spain, 12Hospital Clinic an IDIBAPS, Barcelona, Spain, 13New York University School of Medicine, New York, NY

    Background/Purpose: Nearly 8% of patients with spondyloarthritis (SpA) manifest symptoms that are compatible with active inflammatory bowel disease (IBD), despite not having any previous diagnosis…
  • Abstract Number: 2584 • ACR Convergence 2023

    Gut Microbiome and Intestinal Inflammation in Preclinical Stages of Rheumatoid Arthritis

    Benoît Thomas P. GILBERT1, Raul Yhossef TITO TADEO2, Céline LAMACCHIA1, Olivia STUDER1, Delphine COURVOISIER1, Jeroen RAES3 and Axel Finckh4, 1Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland, 2Center for Microbiology, VIB, Leuven. Laboratory of Molecular Bacteriology, Department of Microbiology and Immunology, Rega Institute, Katholieke Universiteit Leuven, Leuven, Belgium, 3Center for Microbiology, VIB, Leuven. Laboratory of Molecular Bacteriology, Department of Microbiology and Immunology, Rega Institute, Katholieke Universiteit Leuven., Leuven, Belgium, 4HUG, Geneva, Switzerland

    Background/Purpose: We attempted to replicate and expand previous findings of an increased abundance of Prevotellaceae in early untreated Rheumatoid Arthritis (RA) or its preclinical stages,…
  • Abstract Number: 1723 • ACR Convergence 2023

    3,3-dimethyl-1-butanol and Its Metabolite 3,3-dimethylbutyrate Ameliorate Arthritis Severity in CIA Independent of Choline TMA Lyase Activity

    Brendan Allen1, Sabrina Fechtner2, Meagan Chriswell3, Widian Jubair1, M. Aaron Vrolijk1, V. Michael Holers4 and kristine Kuhn1, 1University of Colorado School of Medicine, Aurora, CO, 2University of Colorado Anschutz Medical Campus, Aurora, CO, 3University of Colorado Anschutz SOM, Denver, CO, 4University of Colorado, Denver, CO

    Background/Purpose: Both human and animal studies associate specific microbiota and microbial metabolic pathways with the development of RA and autoimmune arthritis, thereby providing a novel…
  • Abstract Number: 1730 • ACR Convergence 2023

    Gut Microbiota Dysbiosis Impact Autonomic Function in Rheumatoid Arthritis Patients

    Rachel AUDO1, Jérome Thireau2, Louis Rauzier3, Marie Barozet1, JACQUES MOREL4, Patrice Bideaux3, alain Lacampagne2 and Claire Daien5, 1CHU Montpellier, Montpellier, France, 2PhyMedExp INSERM U1046, Montpellier, France, 3PhyMedExp U1046, Montpellier, France, 4Protocole thérapeutique immuno-rhumatologie, Montpellier, France, 5University Hospital, Montpellier, France

    Background/Purpose: Rheumatoid arthritis (RA) is associated with a high risk of cardiovascular (CV) risks, including accelerated atherosclerosis, left ventricular hypertrophy and decreased heart rate variability…
  • Abstract Number: 1740 • ACR Convergence 2023

    Exploring Disease-Associated DNA Methylome Alterations in Rheumatoid Arthritis: Potential Diagnostic and Prognostic Biomarkers

    Arkaitz Mucientes1, Martín-Núñez Gracia María2, José Lisbona-Montañez3, Patricia Ruiz-Limon4, Rocío Redondo-Rodríguez5, SARA MANRIQUE6, Inmaculada Ureña5, Laura Cano-García5, Isabel Moreno-Indias1, Natalia Mena Vazquez7 and Antonio Fernandez-Nebro8, 1IBIMA Plataforma BIONAND, Málaga, Spain, 2Universidad de Málaga, Departamento de Medicina y Dermatología, Málaga, Spain, 3Universidad de Málaga, Departamento de Medicina y Dermatología, Moclinejo, Spain, 4IBIMA Plataforma BIONAND, Cordoba, Spain, 5Division of Rheumatology, Hospital Regional Universitario Carlos Haya, Málaga, Spain, 6Division of Rheumatology, Hospital Regional Universitario Carlos Haya, Malaga, Spain, 7IBIMA, Málaga, Spain, 8Hospital Regional Universitario de Málaga, Malaga, Spain

    Background/Purpose: The etiology of rheumatoid arthritis (RA) is not fully understood. It is accepted that RA results from the interplay of genetic and environmental factors.…
  • Abstract Number: 1743 • ACR Convergence 2023

    Individuals At-risk for and with Rheumatoid Arthritis Have Elevated Fecal Concentrations of Arthritogenic Subdoligranulum didolesgii Correlating with CCP3 Antibodies

    Lyndsey Cole1, Sucai Liu2, Brendan Allen2, Marie Feser3, Kristen Demoruelle3, kevin Deane3, Michael Holer3 and kristine Kuhn2, 1University of Colorado School of Medicine, Centennial, CO, 2University of Colorado School of Medicine, Aurora, CO, 3University of Colorado Anschutz Medical Campus, Aurora, CO

    Background/Purpose: Our prior investigation identified a specific strain of Subdoligranulum didolesgii, S. dido7, to which dual IgA/IgG family plasmablast-derived monoclonal autoantibodies from individuals at-risk for…
  • Abstract Number: 0697 • ACR Convergence 2023

    Alterations in Composition and Function of Gut Microbiota in Patients with Large-Vessel Vasculitis

    Adam Mayer1, Weiming Hu2, Kyle Bittinger2, Rui Liang3, Naomi Amudala3, Shubhasree Banerjee3, Peter Merkel3 and Rennie Rhee3, 1University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3University of Pennsylvania, Philadelphia, PA

    Background/Purpose: The gut microbiome has a critical role in immune homeostasis and there is growing interest in understanding the relationship between the microbiome and autoimmunity.…
  • Abstract Number: 1768 • ACR Convergence 2023

    The Dynamics of the Gut Microbiome in Rheumatoid Arthritis Susceptibility: A Cross-Sectional and Longitudinal Observational Study

    Christopher Rooney1, Ian Jeffery2, Kulveer Mankia3, Mark Wilcox1 and Paul Emery4, 1University of Leeds, Leeds, United Kingdom, 24D Pharma plc, Cork, Ireland, 3Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

    Background/Purpose: Multiple compositional shifts of gut microbiota have been identified within the rheumatoid arthritis (RA) disease continuum, encompassing both established RA and at-risk individuals (including…
  • Abstract Number: 0773 • ACR Convergence 2023

    Sputum Lautropia Abundance Is Decreased in Rheumatoid Arthritis-Associated Pulmonary Fibrosis and Correlates with Lung Disease Severity

    Timothy Wilson1, Brendan Allen2, jonathan harris3, Stephen Humphries4, kristine Kuhn2, kevin Deane3, joyce Lee5, joshua Solomon4 and Kristen Demoruelle3, 1Thomas Jefferson University, Philadelphia, PA, 2University of Colorado School of Medicine, Aurora, CO, 3University of Colorado Anschutz Medical Campus, Aurora, CO, 4National Jewish Health, Denver, CO, 5University of Colorado Anschutz Campus, Denver, CO

    Background/Purpose: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) develops in 5-10% of RA patients and more often manifests as the fibrotic subtype of ILD known as…
  • Abstract Number: 1774 • ACR Convergence 2023

    Gut Microbiota and Permeability Biomarkers for Diagnosis and Prognosis in Rheumatoid Arthritis Associated Interstitial Lung Disease

    José Lisbona-Montañez1, Patricia Ruiz-Limon2, Arkaitz Mucientes3, Natalia Mena Vazquez4, Isabel Moreno-Indias3, SARA MANRIQUE5, Laura Cano-García6, Rocío Redondo-Rodríguez6, Francisco J tinahones3 and Antonio Fernandez-Nebro7, 1Universidad de Málaga, Departamento de Medicina y Dermatología, Moclinejo, Spain, 2IBIMA Plataforma BIONAND, Cordoba, Spain, 3IBIMA Plataforma BIONAND, Málaga, Spain, 4IBIMA, Málaga, Spain, 5Division of Rheumatology, Hospital Regional Universitario Carlos Haya, Malaga, Spain, 6Division of Rheumatology, Hospital Regional Universitario Carlos Haya, Málaga, Spain, 7Hospital Regional Universitario de Málaga, Malaga, Spain

    Background/Purpose: Gut microbiota has been related to rheumatoid arthritis (RA), inflammation, and it's severity. Interstitial lung disease (ILD) is the most frequent non-pleural pulmonary manifestation…
  • Abstract Number: 0778 • ACR Convergence 2023

    The Effect of Probiotic Modulation of Enteral Dysbiosis on Disease Activity in Patients with Psoriatic Arthritis – A Randomized Controlled Trial

    Anirudh Subramanian Muralikrishnan1, Barbara Dreo2, Angelika Lackner1, Rusmir Husic3, Florentine Moazedi-Fuerst3, Josef Hermann4, Philipp Bosch1, Johannes Fessler1, Jens Thiel5 and Martin Stradner1, 1Medical University of Graz, Graz, Austria, 2Division of Rheumatology and Immunology, Medical University of Graz, Graz, Austria, 3Meduni Graz, Graz, Austria, 4Division of Rheumatology and Immunology, Department of Internal Medicine, Medical University Graz, Graz, Austria, 5University Hospital Freiburg, Freiburg, Germany

    Background/Purpose: Psoriatic Arthritis (PsA) is a painful disease of the joints and spine. Recent studies have described enteric dysbiosis as a possible pathological mechanism in…
  • Abstract Number: 1785 • ACR Convergence 2023

    Machine Learning Models Identify Gut Microbiota That Predict Chronicity in Reactive Arthritis

    Prakashini MV1, Soumendu Mahapatra2, Krushna Chandra Murmu2, Rasmita Mishra2, Prasanta Padhan1, Punit Prasad2, Ramnath Misra3 and Sakir Ahmed4, 1Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India, 2Institute of Life Sciences, Bhubaneswar, India, 3Kalinga Institute of Medical Sciences, KIIT University, Lucknow, India, 4Kalinga Institute of Medical Sciences, Bhubaneswar, India

    Background/Purpose: Reactive arthritis (ReA) is the unique infection-triggered spondyloarthritis (SpA). Undifferentiated peripheral SpA (UpSpA) is similar but without previous infection, or psoriasis or inflammatory bowel…
  • Abstract Number: 0794 • ACR Convergence 2023

    Microbiota-dependent Indole Production Is Required for the Development of Collagen-induced Arthritis

    Brenda Seymour1, Brandon Trent2, Brendan Allen3, Sucai Liu3, Sunny Sneed4, Robert Anthony4 and kristine Kuhn3, 1University of Colorado School of Medicine, Denver, CO, 2University of Colorado School of Medicine, Eugene, OR, 3University of Colorado School of Medicine, Aurora, CO, 4Harvard Medical School, Boston, MA

    Background/Purpose: While alterations in tryptophan (Trp) metabolism have been broadly implicated across autoimmune diseases (including RA, SpA, SLE, and MS), the specific role(s) of Trp…
  • Abstract Number: 1786 • ACR Convergence 2023

    Newly Identified Gut Commensal Clostridium Fessum AM100 for Treating Ankylosing Spondylitis

    Lu Bai1, Chengkai Zhu1, Yihong Xu2, Kunhai Tang1, Dachun Zhuo1, Qing Zhang1, Chengchun Geng1, Weidong Xu2, Hao Wu1, Xingdong Chen1 and Jiucun Wang1, 1Fudan University, Shanghai, China, 2Changhai Hospital, Shanghai, China

    Background/Purpose: Ankylosing spondylitis (AS) is an inflammatory disease of the spinal joints leading to progressive loss of spinal mobility and chronic pain. Gutdysbiosis has been…
  • Abstract Number: 0829 • ACR Convergence 2023

    Decreased History of Breastfeeding During Infancy in Juvenile Spondyloarthritis: A Case-Control Study

    Katelyn Baggett1, Timothy G. Brandon2, Rui Xiao3 and Pamela F. Weiss4, 1Penn State College of Medicine, Newtown Square, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Department of Pediatrics Division of Biostatistics, Children's Hospital of Philadelphia, Philadelphia, PA, 4Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: The pathogenesis of juvenile spondyloarthritis (JSpA) is multifactorial, and includes a genetic predisposition of the HLA-B27 allele, and environmental exposures such as the microbiome.…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology